Peter Attia
FollowThe latest interviews, podcast appearances, and blog posts from Peter Attia, updated daily.
#408 ‒ AMA #89: Thyroid health: interpreting symptoms, diagnosing and treating dysfunction, and navigating the gray zone
“The goal of this podcast, of course, is then to walk people through the physiology carefully enough that you can see both the grains of truth on each side of those schools of thought, but perhaps…
Can semaglutide slow aging?
A new study found that semaglutide extended median lifespan and improved several measures of aging in female mice—but the headline requires careful interpretation.
Nearsightedness is rising. Are screens to blame?
How screens, outdoor light, and near work may influence…
Vaginal estrogen: a potentially life-saving therapy
Local estrogen therapy treats symptoms, prevents UTIs, is safe, and likely saves…
GLP-1 medications beyond weight loss: how far could their benefits extend?
What the evidence says about their growing list of established and emerging…
Gum recession: a common oral health issue that often goes unnoticed
Gum recession is common, often silent, and sometimes worsened by the very habits meant to protect your teeth.
Multifactorial trials: taking apart the kitchen sink
What a multifactorial trial can prove, what it can't, and why the difference matters more than it…
Does protein restriction still make sense in modern kidney care?
The case for limiting protein to protect the kidneys was built in a different era of nephrology.
Zero coronary calcium does not mean zero cardiovascular risk
A zero calcium score is useful, but it should not be used to dismiss sustained LDL-C elevation in young adults.